TikTok Content Creators Fueling Parallel Market for Unlicensed Weight-Loss Drug

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and assertions of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is worrisome and could result in users administering substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Elimination

Based on TikTok, the platform has removed problematic material and banned related keywords and query recommendations. The company stated it was dedicated to keeping the service secure and investing in strengthening enforcement strategies.

Digital Trading Operations

Research also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, populated with photos of weight loss, positive testimonials and detailed guides for preparing or administering at residence.

Within moments of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these communities, messages show black plastic packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how long a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it regularly monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they cannot confirm. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant medical dangers”.